U.S. Firm Set To Sue S. Korea Dog Cloner Tied To Disgraced Scientist
This article was originally published in PharmAsia News
Executive Summary
A U.S. company is reported set to file suit in South Korea, charging a patent violation involving the country's disgraced South Korean cloning scientist. Start Licensing, which holds a license from the U.K.'s Roslin Institute, famous for cloning Dolly the sheep, has hired a South Korean patent lawyer to sue RNL Bio of South Korea, a commercial dog-cloning company. Start says it licensed commercial rights for the Roslin technology to BioArts, which in turn relies on the work of Hwang Woo-suk, infamous South Korean stem cell cloner. A former Hwang collaborator provides cloning technology to RNL, completing the circle of involvement and alleged conflict. (Click here for more